Skip to main content

WELLS FARGO & COMPANY/MN

Position in RLMD — Relmada Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in RLMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$596,939
+$596,835 QoQ
Shares Held
86,263
+43031.5% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 126 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLMD Over Time

Shares Held

Position Value (USD)

Derivatives in RLMD

reported options exposure · as of Sep 30, 2022
CallValue
$1,214,256
CallShares
32,800
PutValue
$436,836
PutShares
11,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. RLMD ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLMD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $596,939 86,263
2024-12-31 $104 200
2024-09-30 $1,134 350
2024-06-30 $1,050 350
2024-03-31 $2,524 543
2023-12-31 $2,235 540
2023-09-30 $1,590 530
2023-06-30 $1,313 534
2023-03-31 $12,124 5,365
2022-12-31 $3,989 1,143
2022-09-30 $1,214,256 32,800
2022-09-30 $808,996 21,853
2022-09-30 $436,836 11,800
2022-06-30 $475,357 25,032
2022-06-30 $379,800 20,000
2022-03-31 $653,966 24,230
2021-12-31 $189,003 8,389
2021-09-30 $33,365 1,273
2021-06-30 $305,535 9,545
2021-03-31 $433,505 12,312
2020-12-31 $1,383,305 43,134
2020-09-30 $1,314,630 34,945
2020-06-30 $1,743,369 38,958
2020-03-31 $398,574 11,685